These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25938431)

  • 1. Violacein Treatment Modulates Acute and Chronic Inflammation through the Suppression of Cytokine Production and Induction of Regulatory T Cells.
    Verinaud L; Lopes SC; Prado IC; Zanucoli F; Alves da Costa T; Di Gangi R; Issayama LK; Carvalho AC; Bonfanti AP; Niederauer GF; Duran N; Costa FT; Oliveira AL; Höfling MA; Machado DR; Thomé R
    PLoS One; 2015; 10(5):e0125409. PubMed ID: 25938431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
    Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
    J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.
    Thomé R; Moraes AS; Bombeiro AL; Farias Ados S; Francelin C; da Costa TA; Di Gangi R; dos Santos LM; de Oliveira AL; Verinaud L
    PLoS One; 2013; 8(6):e65913. PubMed ID: 23799062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
    Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midkine inhibits inducible regulatory T cell differentiation by suppressing the development of tolerogenic dendritic cells.
    Sonobe Y; Li H; Jin S; Kishida S; Kadomatsu K; Takeuchi H; Mizuno T; Suzumura A
    J Immunol; 2012 Mar; 188(6):2602-11. PubMed ID: 22323540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells.
    Lavasani S; Dzhambazov B; Nouri M; Fåk F; Buske S; Molin G; Thorlacius H; Alenfall J; Jeppsson B; Weström B
    PLoS One; 2010 Feb; 5(2):e9009. PubMed ID: 20126401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of human adipose tissue-derived stem cell (hADSC) transplantation on experimental autoimmune encephalomyelitis (EAE) mice.
    Li J; Chen Y; Chen Z; Huang Y; Yang D; Su Z; Weng Y; Li X; Zhang X
    Sci Rep; 2017 Feb; 7():42695. PubMed ID: 28198408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal immune activation in late gestation increases neuroinflammation and aggravates experimental autoimmune encephalomyelitis in the offspring.
    Zager A; Peron JP; Mennecier G; Rodrigues SC; Aloia TP; Palermo-Neto J
    Brain Behav Immun; 2015 Jan; 43():159-71. PubMed ID: 25108214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis.
    Ochoa-Repáraz J; Mielcarz DW; Ditrio LE; Burroughs AR; Foureau DM; Haque-Begum S; Kasper LH
    J Immunol; 2009 Nov; 183(10):6041-50. PubMed ID: 19841183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells restrain CD4+ T cells from causing unregulated immune activation and hypersensitivity to lipopolysaccharide challenge.
    Okeke EB; Okwor I; Uzonna JE
    J Immunol; 2014 Jul; 193(2):655-62. PubMed ID: 24943218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
    Sun JB; Czerkinsky C; Holmgren J
    J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis.
    Lee JH; Kim TH; Park HE; Lee EG; Jung NC; Song JY; Seo HG; Seung KB; Chang K; Lim DS
    Cardiovasc Res; 2014 Feb; 101(2):203-10. PubMed ID: 24189626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of experimental autoimmune encephalitis by novel peptides: involvement of T regulatory cells.
    Shapira E; Brodsky B; Proscura E; Nyska A; Erlanger-Rosengarten A; Wormser U
    J Autoimmun; 2010 Aug; 35(1):98-106. PubMed ID: 20434883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG35-55-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice.
    Zhang L; Guo Y; Xia CQ
    J Immunol Res; 2015; 2015():129682. PubMed ID: 26258148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis.
    McDonald CA; Payne NL; Sun G; Moussa L; Siatskas C; Lim R; Wallace EM; Jenkin G; Bernard CC
    J Neuroinflammation; 2015 Jun; 12():112. PubMed ID: 26036872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis.
    Guo Y; Chan KH; Lai WH; Siu CW; Kwan SC; Tse HF; Wing-Lok Ho P; Wing-Man Ho J
    Neuroimmunomodulation; 2013; 20(5):294-303. PubMed ID: 23899693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
    Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of an autoimmune encephalomyelitis mouse model with nonmyeloablative conditioning and syngeneic bone marrow transplantation.
    Meng L; Ouyang J; Zhang H; Wen Y; Chen J; Zhou J
    Restor Neurol Neurosci; 2011; 29(3):177-85. PubMed ID: 21586824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.